FR2449685B1 - Agent antihypercholesterolemique prepare par culture de microorganismes du genre monascus et son procede de preparation - Google Patents

Agent antihypercholesterolemique prepare par culture de microorganismes du genre monascus et son procede de preparation

Info

Publication number
FR2449685B1
FR2449685B1 FR8003662A FR8003662A FR2449685B1 FR 2449685 B1 FR2449685 B1 FR 2449685B1 FR 8003662 A FR8003662 A FR 8003662A FR 8003662 A FR8003662 A FR 8003662A FR 2449685 B1 FR2449685 B1 FR 2449685B1
Authority
FR
France
Prior art keywords
microorganisms
culture
preparing
same
agent prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8003662A
Other languages
English (en)
Other versions
FR2449685A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of FR2449685A1 publication Critical patent/FR2449685A1/fr
Application granted granted Critical
Publication of FR2449685B1 publication Critical patent/FR2449685B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR8003662A 1979-02-20 1980-02-20 Agent antihypercholesterolemique prepare par culture de microorganismes du genre monascus et son procede de preparation Expired FR2449685B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンｋおよびその製造法

Publications (2)

Publication Number Publication Date
FR2449685A1 FR2449685A1 (fr) 1980-09-19
FR2449685B1 true FR2449685B1 (fr) 1985-06-28

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8003662A Expired FR2449685B1 (fr) 1979-02-20 1980-02-20 Agent antihypercholesterolemique prepare par culture de microorganismes du genre monascus et son procede de preparation

Country Status (27)

Country Link
JP (1) JPS5925599B2 (fr)
KR (1) KR830002801B1 (fr)
AT (1) AT373915B (fr)
AU (1) AU532626B2 (fr)
BE (1) BE881825A (fr)
CA (1) CA1129794A (fr)
CH (1) CH645890A5 (fr)
DD (1) DD154494A5 (fr)
DE (2) DE3006216C2 (fr)
DK (2) DK149095C (fr)
ES (1) ES8103171A1 (fr)
FI (1) FI66427C (fr)
FR (1) FR2449685B1 (fr)
GB (1) GB2046737B (fr)
HU (1) HU182069B (fr)
IE (1) IE49743B1 (fr)
IT (1) IT1175260B (fr)
MX (1) MX6314E (fr)
NL (1) NL191540C (fr)
NO (1) NO153974C (fr)
NZ (1) NZ192919A (fr)
PH (1) PH15145A (fr)
PL (1) PL124304B1 (fr)
SE (1) SE453301B (fr)
SG (1) SG6784G (fr)
SU (2) SU1158048A3 (fr)
ZA (1) ZA80962B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (fr) 1992-02-10 1993-08-11 Jagroop S. Dahiya Nouvelles souches fongiques et leur utilisation pour la production d'antibiotiques
EP0629184A1 (fr) * 1992-03-04 1994-12-21 Fujisawa Pharmaceutical Co., Ltd. DERIVES DE TETRALINE EN TANT QU'INHIBITEURS D'HMG-CoA REDUCTASE
NZ247617A (en) 1992-05-15 1995-07-26 Sankyo Co Octahydronaphthalene oxime derivatives and pharmaceutical compositions
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
IL132822A0 (en) 1998-03-20 2001-03-19 Biogal Gyogyszergyar Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
YU63602A (sh) 2000-02-24 2006-01-16 Biogal Gyogyszergyar Rt. Postupak za prečišćavanje fermentacionog bujona
US6521762B2 (en) 2000-03-03 2003-02-18 BIOGAL Gyógyszergyar RT. Process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (fr) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
EP1357807B1 (fr) 2001-02-09 2007-03-14 Unilever N.V. Produit alimentaire comprenant une proteine de soja et des statines
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 ｋ 생산방법
SI2373609T1 (sl) 2008-12-19 2013-12-31 Krka, D.D., Novo Mesto Uporaba amfifilnih spojin za kontrolirano kristalizacijo statinov in intermediatov statinov
EP2327682A1 (fr) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Utilisation de composés amphiphiles pour la crystallisation controlée de statines et d'intermediaires de statines.
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (fr) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus

Also Published As

Publication number Publication date
JPS5925599B2 (ja) 1984-06-19
IE49743B1 (en) 1985-12-11
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
AT373915B (de) 1984-03-12
SE8001339L (sv) 1980-08-21
GB2046737B (en) 1983-01-12
NZ192919A (en) 1984-07-06
CH645890A5 (de) 1984-10-31
IT8067262A0 (it) 1980-02-20
NL191540C (nl) 1995-09-04
ES488796A0 (es) 1981-02-16
PL222120A1 (fr) 1980-10-20
NL191540B (nl) 1995-05-01
IT1175260B (it) 1987-07-01
DE3051175C2 (fr) 1989-12-21
SU1158048A3 (ru) 1985-05-23
NO800451L (no) 1980-08-21
JPS55111790A (en) 1980-08-28
GB2046737A (en) 1980-11-19
AU5567380A (en) 1980-08-28
ES8103171A1 (es) 1981-02-16
DK149095B (da) 1986-01-20
ATA92980A (de) 1983-07-15
DK21889A (da) 1989-01-18
DK21889D0 (da) 1989-01-18
PL124304B1 (en) 1983-01-31
DD154494A5 (de) 1982-03-24
HU182069B (en) 1983-12-28
KR830002030A (ko) 1983-05-21
IE800321L (en) 1980-08-20
DE3006216A1 (de) 1980-09-04
SE453301B (sv) 1988-01-25
ZA80962B (en) 1981-03-25
SG6784G (en) 1985-02-08
KR830002801B1 (ko) 1983-12-16
NO153974C (no) 1986-06-25
DK73080A (da) 1980-08-21
NL8001041A (nl) 1980-08-22
NO153974B (no) 1986-03-17
DE3006216C2 (de) 1985-10-31
PH15145A (en) 1982-08-24
DK149095C (da) 1986-06-16
FI66427B (fi) 1984-06-29
BE881825A (fr) 1980-08-20
CA1129794A (fr) 1982-08-17
AU532626B2 (en) 1983-10-06
FI800506A (fi) 1980-08-21
MX6314E (es) 1985-04-01
SU969702A1 (ru) 1982-10-30

Similar Documents

Publication Publication Date Title
FR2449685B1 (fr) Agent antihypercholesterolemique prepare par culture de microorganismes du genre monascus et son procede de preparation
FR2483912B1 (fr) Derives hydroxycarboxyles du compose ml-236b, leur procede de preparation et leur application therapeutique
DE2963681D1 (en) Method and apparatus for determining the minimum concentration of antibiotic to inhibit microorganism growth
RO86176A (fr) Procede pour la preparation des esters de l'acide 6-beta-hydro0yalkylpenycillanique
RO81621A (fr) Procede pour la preparation des esters benzyliques a groupe etheriques et/ou thioetheriques substitues a fluor
BE866957A (fr) Procede de preparation d'homopolymerisats et de copolymerisats d'alpha-mono-olefines
FR2336927A1 (fr) Derives de l'isochromane et leur procede de preparation
JPS568619A (en) Culture soil for plant
JPS56102793A (en) Preparation of antibiotic c-15003 p-3
JPS55120790A (en) Fr-900129 substance, its ester, and their preparation
GB2054646B (en) Fermentor for cultures of micro-organisms
DE3065316D1 (en) Process for the production of creatinine iminohydrolase by growing micro-organism and nutrient medium for the practice of said process
BE864481A (fr) Esters m-phenoxybenzyliques d'acides (difluoro-2,2 benzodioxole-1,3)-5- alpha-alkylacetiques utiles comme insecticides et acaricides et procede de leur preparation
BE862621A (fr) Procede de culture de microorganismes
BE877017A (fr) Esters d'hydrocortisone et leur procede de preparation
BE880656A (fr) Derive de 7 alpha-methoxycephalosporine et son procede de preparation
IE40975B1 (en) Isolation of utero-evacuant substances from plant extracts
FR2460328B1 (fr) Procede de production de creatinase et culture du microorganisme producteur
IL58184A (en) Method of irrigating plant cultures and means for practising the method
JPS51125787A (en) Method for cultivating and processing of mashrooms
AU5031079A (en) Method of growing plants
ZA763893B (en) Method for the culture of monocellular microorganisms and microorganism obtained thereby
SE7707467L (sv) Forfarande for framstellning av en antibiotisk substans
JPS565022A (en) Constituting method of culture bed for plant
IT7850955A0 (it) Procedimento per la coltura aerobica di microorganismi